Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Joshua L. Gowin

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Research 
    Collapse research activities and funding
    R00AA024778     (GOWIN, JOSHUA LEIGH)Sep 1, 2018 - Aug 31, 2021
    Neural Correlates of Emotion Regulation in Youth at Risk for Alcoholism
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ernst M, Gowin JL, Gaillard C, Philips RT, Grillon C. Sketching the Power of Machine Learning to Decrypt a Neural Systems Model of Behavior. Brain Sci. 2019 Mar 20; 9(3). PMID: 30897793.
      View in: PubMed
    2. Tanabe J, Regner M, Sakai J, Martinez D, Gowin J. Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment. Br J Radiol. 2019 Mar 11; 20180942. PMID: 30855982.
      View in: PubMed
    3. Sloan ME, Gowin JL, Janakiraman R, Ester CD, Stoddard J, Stangl B, Ramchandani VA. High-risk social drinkers and heavy drinkers display similar rates of alcohol consumption. Addict Biol. 2019 Mar 01. PMID: 30821409.
      View in: PubMed
    4. Gowin JL, Ernst M, Ball T, May AC, Sloan ME, Tapert SF, Paulus MP. Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models. Neuroimage Clin. 2019; 21:101676. PMID: 30665102.
      View in: PubMed
    5. Gowin J, Sloan ME, Swan JE, Momenan R, Ramchandani VA. The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology. Psychopharmacology (Berl). 2019 Feb; 236(2):775-785. PMID: 30456539.
      View in: PubMed
    6. Sloan ME, Grant CW, Gowin JL, Ramchandani VA, Le Foll B. Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies. Acta Pharmacol Sin. 2019 Mar; 40(3):342-350. PMID: 30166624.
      View in: PubMed
    7. Fede SJ, Gowin JL, Manza P. An Eye for an Eye: Neural Correlates of the Preference for Punishment-Based Justice. J Neurosci. 2018 Aug 29; 38(35):7559-7561. PMID: 30158297.
      View in: PubMed
    8. Suchting R, Gowin JL, Green CE, Walss-Bass C, Lane SD. Genetic and Psychosocial Predictors of Aggression: Variable Selection and Model Building With Component-Wise Gradient Boosting. Front Behav Neurosci. 2018; 12:89. PMID: 29867390.
      View in: PubMed
    9. Sloan ME, Klepp TD, Gowin JL, Swan JE, Sun H, Stangl BL, Ramchandani VA. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption. Neuropsychopharmacology. 2018 06; 43(7):1530-1538. PMID: 29497164.
      View in: PubMed
    10. Gowin JL, Sloan ME, Ramchandani VA, Paulus MP, Lane SD. Differences in decision-making as a function of drug of choice. Pharmacol Biochem Behav. 2018 01; 164:118-124. PMID: 28927583.
      View in: PubMed
    11. Gowin JL, Sloan ME, Stangl BL, Vatsalya V, Ramchandani VA. Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption. Am J Psychiatry. 2017 11 01; 174(11):1094-1101. PMID: 28774194.
      View in: PubMed
    12. Sloan ME, Gowin JL, Ramchandani VA, Hurd YL, Le Foll B. The endocannabinoid system as a target for addiction treatment: Trials and tribulations. Neuropharmacology. 2017 Sep 15; 124:73-83. PMID: 28564576.
      View in: PubMed
    13. Gowin JL, Ball TM, Wittmann M, Tapert SF, Paulus MP. Corrigendum to "Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse" [Drug and Alcohol Dependence 152 (2015) 93-101]. Drug Alcohol Depend. 2017 06 01; 175:255. PMID: 28431752.
      View in: PubMed
    14. Sloan ME, Gowin JL, Yan J, Schwandt ML, Spagnolo PA, Sun H, Hodgkinson CA, Goldman D, Ramchandani VA. Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant. Addict Biol. 2018 01; 23(1):474-484. PMID: 28150397.
      View in: PubMed
    15. Gowin JL, May AC, Wittmann M, Tapert SF, Paulus MP. Doubling down: increased risk-taking behavior following a loss by individuals with cocaine use disorder is associated with striatal and anterior cingulate dysfunction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan; 2(1):94-103. PMID: 28164168.
      View in: PubMed
    16. Gowin JL, Vatsalya V, Westman JG, Schwandt ML, Bartlett S, Heilig M, Momenan R, Ramchandani VA. The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers. Alcohol Clin Exp Res. 2016 05; 40(5):979-87. PMID: 27062270.
      View in: PubMed
    17. Pariyadath V, Gowin JL, Stein EA. Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks. Prog Brain Res. 2016; 224:155-73. PMID: 26822358.
      View in: PubMed
    18. Vatsalya V, Gowin JL, Schwandt ML, Momenan R, Coe MA, Cooke ME, Hommer DW, Bartlett S, Heilig M, Ramchandani VA. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers. Int J Neuropsychopharmacol. 2015 Jul 25; 18(12). PMID: 26209857; PMCID: PMC4675979.
    19. Gowin JL, Ball TM, Wittmann M, Tapert SF, Paulus MP. Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse. Drug Alcohol Depend. 2015 Jul 01; 152:93-101. PMID: 25977206; PMCID: PMC4458160.
    20. Kose S, Steinberg JL, Moeller FG, Gowin JL, Zuniga E, Kamdar ZN, Schmitz JM, Lane SD. Neural correlates of impulsive aggressive behavior in subjects with a history of alcohol dependence. Behav Neurosci. 2015 Apr; 129(2):183-96. PMID: 25664566; PMCID: PMC4777896.
    21. Gowin JL, Harlé KM, Stewart JL, Wittmann M, Tapert SF, Paulus MP. Attenuated insular processing during risk predicts relapse in early abstinent methamphetamine-dependent individuals. Neuropsychopharmacology. 2014 May; 39(6):1379-87. PMID: 24317375; PMCID: PMC3988541.
    22. Gowin JL, Stewart JL, May AC, Ball TM, Wittmann M, Tapert SF, Paulus MP. Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact. Addiction. 2014 Feb; 109(2):237-47. PMID: 24033715; PMCID: PMC3947108.
    23. Gowin JL, Mackey S, Paulus MP. Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):13-21. PMID: 23623507; PMCID: PMC3748224.
    24. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. The role of cortisol and psychopathy in the cycle of violence. Psychopharmacology (Berl). 2013 Jun; 227(4):661-72. PMID: 23371492.
      View in: PubMed
    25. Alcorn JL, Gowin JL, Green CE, Swann AC, Moeller FG, Lane SD. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder. J Neuropsychiatry Clin Neurosci. 2013; 25(3):229-32. PMID: 24026715; PMCID: PMC4777890.
    26. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior. J Psychopharmacol. 2012 Jul; 26(7):982-93. PMID: 21730016; PMCID: PMC4777893.
    27. Gowin JL, Swann AC, Moeller FG, Lane SD. Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology (Berl). 2010 Jul; 210(4):521-31. PMID: 20407761.
      View in: PubMed
    28. Lane SD, Gowin JL. GABAergic modulation of human social interaction in a prisoner's dilemma model by acute administration of alprazolam. Behav Pharmacol. 2009 Oct; 20(7):657-61. PMID: 19667972; PMCID: PMC2952709.
    29. Lane SD, Gowin JL, Green CE, Steinberg JL, Moeller F, Cherek DR. Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior. Pharmacol Biochem Behav. 2009 Apr; 92(2):357-62. PMID: 19353809.
      View in: PubMed
    Gowin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description

    Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)